Search

Your search keyword '"Hui Mian Xu"' showing total 4 results
Start Over Author "Hui Mian Xu" Publication Year Range Last 3 years
4 results on '"Hui Mian Xu"'

1. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023

Author

Feng‐Hua Wang, Xiao‐Tian Zhang, Lei Tang, Qi Wu, Mu‐Yan Cai, Yuan‐Fang Li, Xiu‐Juan Qu, Hong Qiu, Yu‐Jing Zhang, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Chang Wang, Hao Liu, Miao‐Zhen Qiu, Wen‐Long Guan, Sheng‐Xiang Rao, Jia‐Fu Ji, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Zhi‐Wei Zhou, Ai‐Ping Zhou, Jing Jin, Xiang‐Lin Yuan, Feng Bi, Tian‐Shu Liu, Han Liang, Yan‐Qiao Zhang, Guo‐Xin Li, Jun Liang, Bao‐Rui Liu, Lin Shen, Jin Li, and Rui‐Hua Xu

Subjects
Chinese Society of Clinical Oncology (CSCO), gastric cancer, diagnosis, surgery, neoadjuvant, adjuvant, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Abstract

Abstract The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in evidence‐based medicine, healthcare resource availability, and precision medicine. These updates address the differences in epidemiological characteristics, clinicopathological features, tumor biology, treatment patterns, and drug selections between Eastern and Western gastric cancer patients. Key revisions include a structured template for imaging diagnosis reports, updated standards for molecular marker testing in pathological diagnosis, and an elevated recommendation for neoadjuvant chemotherapy in stage III gastric cancer. For advanced metastatic gastric cancer, the guidelines introduce new recommendations for immunotherapy, anti‐angiogenic therapy and targeted drugs, along with updated management strategies for human epidermal growth factor receptor 2 (HER2)‐positive and deficient DNA mismatch repair (dMMR)/microsatellite instability‐high (MSI‐H) patients. Additionally, the guidelines offer detailed screening recommendations for hereditary gastric cancer and an appendix listing drug treatment regimens for various stages of gastric cancer. The 2023 CSCO Clinical Guidelines for Gastric Cancer updates are based on both Chinese and international clinical research and expert consensus to enhance their applicability and relevance in clinical practice, particularly in the heterogeneous healthcare landscape of China, while maintaining a commitment to scientific rigor, impartiality, and timely revisions.

Published
2024
Full Text
View/download PDF

2. Standardizing the classification of gastric cancer patients with limited and adequate number of retrieved lymph nodes: an externally validated approach using real-world data

Author

Wei Wang, Yu-Jie Yang, Ri-Hong Zhang, Jing-Yu Deng, Zhe Sun, Sharvesh Raj Seeruttun, Zhen-Ning Wang, Hui-Mian Xu, Han Liang, and Zhi-Wei Zhou

Subjects
Lymph nodes, Limited, Adequate, Gastric cancer, American Joint Committee on Cancer, Tumor-node-metastasis, Medicine (General), R5-920, Military Science
Abstract

Abstract Background Currently, there is no formal consensus regarding a standard classification for gastric cancer (GC) patients with

Published
2022
Full Text
View/download PDF

3. Progress and remaining challenges in comprehensive gastric cancer treatment

Author

Zhi-Feng Miao, Hanyu Chen, Zhen-Ning Wang, Jia-Fu Ji, Han Liang, Hui-Mian Xu, and Jiping Wang

Abstract

Gastric cancer (GC) is the fifth most common cancer among all cancer fields and currently the third most common cause of cancer-related deaths both in men and women worldwide. Additionally, the incidence and mortality of GC significantly varies due to different eating habits and environmental and genetic factors in different areas. Remarkably, with the development of techniques and surgical equipment along with newly emerging drugs and therapeutics, the 5-year survival for GC patients has increased and the death rate has decreased. In this perspective, based on current therapies in GC field around the world, we present a systematic discussion about the state of advanced clinical treatments including surgical resection, systemic chemotherapy, targeted therapy, radiotherapy and enhanced recovery after surgery. Although challenges remain which require further study and investigation, in this review, we mainly focus on the promising clinical treatment strategies in GC to date.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results